Acute 0 5 0 5 B-chronic_disease
hepatitis 6 15 6 15 I-chronic_disease

Aged 0 4 16 20 B-age
0 5 6 21 22 B-lower_bound
- 7 8 23 24 O
70 9 11 25 27 B-upper_bound
years 12 17 28 33 I-upper_bound

DKC1 0 4 34 38 B-clinical_variable

DLCO 0 4 39 43 B-clinical_variable
≥30 5 8 44 47 O
% 8 9 47 48 I-lower_bound
predicted 10 19 49 58 O

Diagnosis 0 9 59 68 O
of 10 12 69 71 O
DC 13 15 72 74 B-chronic_disease

Diagnosis 0 9 75 84 O
of 10 12 85 87 O
DC 13 15 88 90 B-chronic_disease
with 16 20 91 95 I-chronic_disease
a 21 22 96 97 I-chronic_disease
triad 23 28 98 103 I-chronic_disease
of 29 31 104 106 I-chronic_disease
mucocutaneous 32 45 107 120 I-chronic_disease
features 46 54 121 129 I-chronic_disease

Diagnosis 0 9 130 139 O
of 10 12 140 142 O
Fanconi 13 20 143 150 B-chronic_disease
anemia 21 27 151 157 I-chronic_disease
based 28 33 158 163 O
on 34 36 164 166 O
DEB 37 40 167 170 O

Diagnosis 0 9 171 180 O
of 10 12 181 183 O
SAA 13 16 184 187 B-chronic_disease
with 17 21 188 192 O
refractory 22 32 193 203 B-chronic_disease
cytopenias 33 43 204 214 I-chronic_disease

Diagnosis 0 9 215 224 O
of 10 12 225 227 O
dyskeratosis 13 25 228 240 B-chronic_disease
congenita 26 35 241 250 I-chronic_disease
with 36 40 251 255 O
advanced 41 49 256 264 B-chronic_disease
MDS 50 53 265 268 I-chronic_disease

Dyskeratosis 0 12 269 281 B-chronic_disease
Congenita 13 22 282 291 I-chronic_disease
( 23 24 292 293 I-chronic_disease
DC 24 26 293 295 I-chronic_disease
) 26 27 295 296 I-chronic_disease
with 28 32 297 301 I-chronic_disease
evidence 33 41 302 310 I-chronic_disease
of 42 44 311 313 I-chronic_disease
BM 45 47 314 316 I-chronic_disease
failure 48 55 317 324 I-chronic_disease

Early 0 5 325 330 O
myelodysplastic 6 21 331 346 B-chronic_disease
features 22 30 347 355 O

Glomerular 0 10 356 366 B-clinical_variable
filtration 11 21 367 377 I-clinical_variable
rate 22 26 378 382 I-clinical_variable
( 27 28 383 384 I-clinical_variable
GFR 28 31 384 387 I-clinical_variable
) 31 32 387 388 I-clinical_variable
≥30 33 36 389 392 O
% 36 37 392 393 I-lower_bound
predicted 38 47 394 403 O

Graft 0 5 404 409 B-chronic_disease
failure 6 13 410 417 I-chronic_disease
as 14 16 418 420 O
defined 17 24 421 428 O
by 25 27 429 431 O
blood 28 33 432 437 B-clinical_variable
/ 33 34 437 438 I-clinical_variable
marrow 34 40 438 444 I-clinical_variable
chimerism 41 50 445 454 I-clinical_variable
of 51 53 455 457 O
< 54 55 458 459 O
5 56 57 460 461 B-upper_bound
% 57 58 461 462 I-upper_bound

Pregnant 0 8 463 471 B-pregnancy

Prior 0 5 472 477 B-treatment
radiation 6 15 478 487 I-treatment
therapy 16 23 488 495 I-treatment
( 24 25 496 497 O
applies 25 32 497 504 O
to 33 35 505 507 O
SAA 36 39 508 511 B-chronic_disease
patients 40 48 512 520 O
only 49 53 521 525 O
) 53 54 525 526 O

Refractory 0 10 527 537 B-cancer
cytopenia 11 20 538 547 I-cancer
defined 21 28 548 555 O
by 29 31 556 558 O
bone 32 36 559 563 B-clinical_variable
marrow 37 43 564 570 I-clinical_variable
cellularity 44 55 571 582 I-clinical_variable
< 56 57 583 584 O
50 57 59 584 586 B-upper_bound
% 59 60 586 587 I-upper_bound
( 61 62 588 589 O
with 62 66 589 593 O
< 67 68 594 595 O
30 69 71 596 598 B-upper_bound
% 71 72 598 599 I-upper_bound
residual 73 81 600 608 B-clinical_variable
hematopoietic 82 95 609 622 I-clinical_variable
cells 96 101 623 628 I-clinical_variable
) 101 102 628 629 O

Severe 0 6 630 636 B-treatment
Aplastic 7 15 637 645 I-treatment
Anemia 16 22 646 652 I-treatment
( 23 24 653 654 I-treatment
SAA 24 27 654 657 I-treatment
) 27 28 657 658 I-treatment
primary 29 36 659 666 I-treatment
transplant 37 47 667 677 I-treatment
with 48 52 678 682 O
evidence 53 61 683 691 O
of 62 64 692 694 O
BM 65 67 695 697 B-chronic_disease
failure 68 75 698 705 I-chronic_disease

Severe 0 6 706 712 B-chronic_disease
Aplastic 7 15 713 721 I-chronic_disease
Anemia 16 22 722 728 I-chronic_disease
( 23 24 729 730 I-chronic_disease
SAA 24 27 730 733 I-chronic_disease
) 27 28 733 734 I-chronic_disease
requiring 29 38 735 744 O
a 39 40 745 746 O
2nd 41 44 747 750 B-treatment
transplant 45 55 751 761 I-treatment

Uncontrolled 0 12 762 774 B-chronic_disease
infection 13 22 775 784 I-chronic_disease

With 0 4 785 789 O
or 5 7 790 792 O
without 8 15 793 800 O
clonal 16 22 801 807 B-chronic_disease
cytogenetic 23 34 808 819 I-chronic_disease
abnormalities 35 48 820 833 I-chronic_disease

abnormal 0 8 834 842 O
reticular 9 18 843 852 B-chronic_disease
skin 19 23 853 857 I-chronic_disease
hyperpigmentation 24 41 858 875 I-chronic_disease

absolute 0 8 876 884 B-clinical_variable
neutrophil 9 19 885 895 I-clinical_variable
count 20 25 896 901 I-clinical_variable
< 26 27 902 903 O
500 27 30 903 906 B-upper_bound
/ 30 31 906 907 I-upper_bound
uL 31 33 907 909 I-upper_bound
without 34 41 910 917 O
hematopoietic 42 55 918 931 O
growth 56 62 932 938 O
factor 63 69 939 945 O
support 70 77 946 953 O

absolute 0 8 954 962 B-clinical_variable
reticulocyte 9 21 963 975 I-clinical_variable
count 22 27 976 981 I-clinical_variable
< 28 29 982 983 O
20,000 29 35 983 989 B-upper_bound
/ 35 36 989 990 I-upper_bound
uL 36 38 990 992 I-upper_bound

acute 0 5 993 998 B-cancer
myeloid 6 13 999 1006 I-cancer
leukemia 14 22 1007 1015 I-cancer
with 23 27 1016 1020 O
> 28 29 1021 1022 O
30 29 31 1022 1024 B-lower_bound
% 31 32 1024 1025 I-lower_bound
blasts 33 39 1026 1032 O

cirrhosis 0 9 1033 1042 B-chronic_disease
on 10 12 1043 1045 O
biopsy 13 19 1046 1052 B-treatment

hemoglobin 0 10 1053 1063 B-clinical_variable
< 11 12 1064 1065 O
9g 12 14 1065 1067 B-upper_bound
/ 14 15 1067 1068 I-upper_bound
uL 15 17 1068 1070 I-upper_bound

left 0 4 1071 1075 B-clinical_variable
ventricular 5 16 1076 1087 I-clinical_variable
ejection 17 25 1088 1096 I-clinical_variable
fraction 26 34 1097 1105 I-clinical_variable
≥ 35 36 1106 1107 O
35 37 39 1108 1110 B-lower_bound
% 39 40 1110 1111 I-lower_bound
with 41 45 1112 1116 O
no 46 48 1117 1119 O
evidence 49 57 1120 1128 O
of 58 60 1129 1131 O
decompensated 61 74 1132 1145 B-chronic_disease
heart 75 80 1146 1151 I-chronic_disease
failure 81 88 1152 1159 I-chronic_disease

nail 0 4 1160 1164 B-chronic_disease
dystrophy 5 14 1165 1174 I-chronic_disease

oral 0 4 1175 1179 B-cancer
leukoplakia 5 16 1180 1191 I-cancer

platelets 0 9 1192 1201 B-clinical_variable
< 10 11 1202 1203 O
20,000 11 17 1203 1209 B-upper_bound
/ 17 18 1209 1210 I-upper_bound
uL 18 20 1210 1212 I-upper_bound

platelets 0 9 1213 1222 B-clinical_variable
< 10 11 1223 1224 O
50,000 11 17 1224 1230 B-upper_bound
/ 17 18 1230 1231 I-upper_bound
uL 18 20 1231 1233 I-upper_bound

refractory 0 10 1234 1244 B-chronic_disease
cytopenias 11 21 1245 1255 I-chronic_disease

requirement 0 11 1256 1267 O
for 12 15 1268 1271 O
G 16 17 1272 1273 B-treatment
- 17 18 1273 1274 I-treatment
CSF 18 21 1274 1277 I-treatment
or 22 24 1278 1280 O
GM 25 27 1281 1283 B-treatment
- 27 28 1283 1284 I-treatment
CSF 28 31 1284 1287 I-treatment
or 32 34 1288 1290 O
erythropoietin 35 49 1291 1305 B-treatment

requirement 0 11 1306 1317 O
for 12 15 1318 1321 O
red 16 19 1322 1325 B-treatment
blood 20 25 1326 1331 I-treatment
cell 26 30 1332 1336 I-treatment
and/or 31 37 1337 1343 I-treatment
platelet 38 46 1344 1352 I-treatment
transfusions 47 59 1353 1365 I-treatment

severe 0 6 1366 1372 B-chronic_disease
portal 7 13 1373 1379 I-chronic_disease
fibrosis 14 22 1380 1388 I-chronic_disease

transfusion 0 11 1389 1400 B-treatment
dependent 12 21 1401 1410 I-treatment

